Genitourinary Cancer
Conference Coverage
AUA: Renal mass biopsy trend tied to nonsurgical RCC treatment
Renal mass biopsy has traditionally played a restricted diagnostic role, but with its improved diagnostic accuracy, it is becoming a viable...
News
Prostate cancer screening for men over 50 has declined
Key clinical point: Prostate cancer screening rates among men aged 50 years and older declined nationwide from 2010 to 2013. Major finding: From...
News
ASCO: Two hits and a miss against advanced urothelial cancer
Key clinical point: Anti PD-L1 immunotherapies were effective in early clinical trials against advanced urothelial cancers. Major finding: The...
Conference Coverage
ASCO: Research IDs new subtype of refractory prostate cancer
Key clinical point: Researchers have identified an aggressive new histologic subset of metastatic castration-resistant prostate cancer. Major...
Conference Coverage
VIDEO: Dr. Walter M. Stadler gives take-home messages from ASCO 2015 GU sessions
Video
VIDEO: More aggressive treatment with docetaxel boosts survival in prostate cancer
Video
VIDEO: Genomic biomarker predicts pembrolizumab response
News
Additive radiotherapy’s advantages outweigh QOL disadvantages
Key clinical point: In locally advanced prostate cancer, adding radiotherapy to androgen-deprivation therapy improves survival with only modest...
News
ASCO 2015: Dr. Walter M. Stadler gives his top picks in genitourinary research
Conference Coverage
AUA: Very low-risk prostate cancers cause few deaths over 15 years
NEW ORLEANS – Long-term active surveillance seems to be a safe and effective way to avoid overtreatment in men with low- and very low-risk...
Conference Coverage
ASCO: Upfront chemo prolongs life in men with advanced, hormone-naive prostate cancer
Key clinical point: Addition of chemotherapy to first-time hormone therapy improves survival in men with advanced prostate cancer. Major finding:...